Hosted on MSN
Kringle Pharma’s Phase 3 Study on KP-100LI: A Potential Game-Changer for Vocal Fold Scar Treatment
Kringle Pharma, Inc. ((JP:4884)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results